REGISTRO DE DERMATITIS DE CONTACTO DE LA AEDV.

[[Translated article]]Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).

Couselo-Rodríguez C; (...); Flórez Á

Article. 10.1016/j.ad.2023.07.028. 2024

• 
• 
• PlumX Metrics

  

  • Captures
    • Readers: 5

  see details

[[Translated article]]Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC).

Verdaguer-Faja, J.; (...); Carrascosa, J. M.

Article. 10.1016/j.ad.2024.04.013. 2024

• 
• 
• 1

  

[[Translated article]]RF-Personalized Medicine to Treat Atopic Dermatitis: In Search for Predictive Biomarkers.

Lasheras-Perez, M A, Navarro-Blanco, F, Rodriguez-Serna, M

Article. 10.1016/j.ad.2024.04.007. 2024

[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings.

Munera-Campos M; (...); Carrascosa JM

Article. 10.1016/j.ad.2023.05.010. 2023

• 
• 
• 4

  

[Translated article] Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC).

Mora-Fernandez, V; (...); Carrascosa, J M

Article. 10.1016/j.ad.2022.02.015. 2022

• 
• 
• 2

  

[Translated article] Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends.

Tous-Romero F; (...); Ortiz-de Frutos J

Article. 10.1016/j.ad.2024.02.006. 2024

[Translated article] RF-Longer Dupilumab Dosing Intervals in Atopic Dermatitis: Optimization or Therapeutic Failure?

Lasheras-Perez, M A, Navarro-Blanco, F, Rodriguez-Serna, M

Article. 10.1016/j.ad.2024.07.008. 2024

2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?

Gatica-Ortega ME; (...); Borrego L

Article. 10.1111/cod.14520. 2024

• 
• 
• 4

  

Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC).

Chicharro P; (...); Sánchez-Pérez J

Article. 10.1111/cod.14672. 2024

• 
• PlumX Metrics

  

  • Citations
    • Citation Indexes: 1
  • Captures
    • Readers: 6
  • Mentions
    • News Mentions: 5

  see details
• 1

  

Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain.

Tous-Romero, Fatima; (...); Ortiz-de Frutos, Francisco Javier

Letter. 10.1111/jdv.18595. 2022

• 
• PlumX Metrics

  

  • Citations
    • Citation Indexes: 3
  • Captures
    • Readers: 6

  see details
• 4

  

Atypical bullae in hands and trunk: An unusual suspect

Palacios-Diaz, Rodolfo David, Lasheras-Perez, Miguel Antonio, Rodriguez-Serna, Mercedes

Editorial Material. 10.1016/j.eimc.2023.12.010. 2024

Atypical bullae in hands and trunk: An unusual suspect.

Palacios-Diaz, Rodolfo David, Lasheras-Perez, Miguel Antonio, Rodriguez-Serna, Mercedes

Case Reports. 10.1016/j.eimce.2023.12.003. 2024

BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings.

Munera-Campos M; (...); Carrascosa JM

Article. 10.1016/j.ad.2023.03.001. 2023

• 
• 
• 5

  

Candidate Allergens for Inclusion in the Spanish Standard Series Based on Data from the Spanish Contact Dermatitis Registry.

Hernández-Fernández CP; (...); Borrego Hernando L

Article. 10.1016/j.ad.2021.05.005. 2021

• 
• PlumX Metrics

  

  • Citations
    • Policy Citations: 2
    • Citation Indexes: 22
  • Captures
    • Readers: 29

  see details
• 21

  

Contact allergy to formaldehyde releasers. Prospective multicenter study.

Sanz-Sánchez T; (...); Arnau AMG

Editorial Material. 10.1111/cod.13417. 2020

• 
• PlumX Metrics

  

  • Citations
    • Citation Indexes: 8
    • Policy Citations: 1
  • Captures
    • Readers: 16

  see details
• 10

  

Cutaneous sarcoidosis after platelet-rich plasma injections and permanent eyebrow make-up.

Torregrosa DM; (...); Estrada RB

Case Reports. 10.1016/j.ad.2023.06.023. 2024

• 
• 
• PlumX Metrics

  

  • Captures
    • Readers: 5

  see details

Cyclosporine 0.1% (Ikervis ) treatment in steroid-dependent dupilumab-associated conjunctivitis.

Roca-Ginés J; (...); Navarro-Mira MÁ

Article. 10.1016/j.oftal.2019.04.013. 2019

• 
• PlumX Metrics

  

  • Citations
    • Citation Indexes: 9
  • Captures
    • Readers: 13
  • Social Media
    • Shares, Likes & Comments: 1

  see details
• 10

  

Characterizing chronic hepatitis delta in Spain and the gaps in its management

Rodriguez-Tajes, Sergio; (...); Lens, Sabela

Meeting Abstract. 2023

Characterizing Hepatitis Delta in Spain and the gaps in its management.

Rodriguez-Tajes, Sergio; (...); Lens, Sabela

Article. 10.1016/j.gastrohep.2024.502222. 2024

• 
• 
• 1

  

Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study

Lasheras-Pérez MA; (...); Rodríguez-Serna M

Article. 10.1111/ijd.17030. 2024

Dupilumab for atopic dermatitis during pregnancy and breastfeeding: Clinical experience in 13 patients.

Escolà H; (...); Curto-Barredo L

Letter. 10.1111/jdv.19165. 2023

• 
• 15

  

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

Casanova MJ; (...); Gisbert JP

Article. 10.1093/ibd/izz192. 2020

• 
• 
• 49

  

Effectiveness and Safety of the Switch from Remicade (R) to CT-P13 in Patients with Inflammatory Bowel Disease

Chaparro, M; (...); Gisbert, JP

Article. 10.1093/ecco-jcc/jjz070. 2019

• 
• 
• 26

  

Effectiveness in the treatment of solar urticaria with omalizumab: Report of 7 cases

Sahuquillo-Torralba, A, Rodriguez-Serna, M, Botella Estrada R

Letter. 10.1016/j.medcli.2018.01.003. 2018

Emicizumab-induced photosensitivity.

Asensi Canto, Pedro; (...); Haya Guaita, Saturnino

Article. 10.1055/s-0042-1749092. 2022

• 
• 1

  

EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.

Chaparro M; (...); Gisbert JP

Article. 10.1177/1756284819847034. 2019

• 
• 
• 18

  

Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC).

Verdaguer-Faja J; (...); Carrascosa JM

Article. 10.1016/j.ad.2024.02.009. 2024

Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC).

Mora-Fernandez, V; (...); Carrascosa, J. M.

Article. 10.1016/j.ad.2021.10.002. 2022

• 
• 
• 2

  

Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Chaparro, M; (...); EpidemIBD Grp

Meeting Abstract. 10.1093/ecco-jcc/jjy222.914. 2019

• 
• 6

  

Folliculitis Decalvans Caused by Bacterial Superinfection Secondary to Erlotinib.

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Letter. 10.1016/j.ad.2017.02.032. 2018

• 3

  

Four-year epidemiological surveillance of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC): Current situation and trends.

Romero FT; (...); de Frutos JO

Article. 10.1016/j.ad.2023.10.039. 2024

• 
• 
• 2

  

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease

Chaparro, M; (...); Gisbert, JP

Meeting Abstract. 2019

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease.

Chaparro M; (...); Gisbert JP

Article. 10.1177/1756284819867848. 2019

• 
• 
• 4

  

Guselkumab, Risankizumab, and Tildrakizumab demonstrate parallel effectiveness and safety in psoriasis treatment: a head-to-head comparative study in real clinical practice.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1016/j.abd.2024.04.004. 2024

Innovations of Spanish code of medical deontology

Lasheras-Pérez MA; (...); Unamuno Bustos B

Letter. 10.1016/j.semerg.2023.102137. 2024

La eutanasia en el régimen penitenciario español.

Lasheras-Pérez MA; (...); Rodríguez-Serna M

Letter. 10.1016/j.semerg.2024.102219. 2024

Longer dupilumab dosing intervals in atopic dermatitis: optimization or therapeutic failure?

Lasheras-Pérez MA, Navarro-Blanco F, Rodríguez-Serna M

Article. 10.1016/j.ad.2023.04.043. 2024

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

Martinez-Camprecios, Joan; (...); Buti, Maria

Article. 10.1016/j.gastrohep.2022.12.004. 2023

• 
• 1

  

Paraoxonase I Activity and Its Relationship with Nutrition in Amyotrophic Lateral Sclerosis.

Proaño B; (...); de la Rubia Ortí JE

Article. 10.3390/antiox13081021. 2024

Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023.

Pesqué D; (...); Giménez-Arnau AM

Article. 10.1111/cod.14702. 2024

Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain.

Docampo-Simon, Alexandre; (...); Silvestre, Juan F.

Article. 10.1089/derm.2022.0023. 2023

• 
• 6

  

Patch testing with formaldehyde 2% aq. - A multicenter study in Spain.

Sanz-Sánchez T; (...); Giménez Arnau AM

Article. 10.1111/cod.13361. 2019

• 
• 
• 6

  

Personalized medicine to treat atopic dermatitis: in search for predictive biomarkers.

Lasheras-Perez, M A, Navarro-Blanco, F, Rodriguez-Serna, M

Article. 10.1016/j.ad.2023.02.041. 2024

Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis.

Pesque, David; (...); Gimenez-Arnau, Ana Maria

Article. 10.1111/jdv.19934. 2024

• 
• 5

  

Porto sinusoidal vascular liver disorder: natural history and long-term outcome

Magaz, Marta; (...); Garcia Pagan, Juan Carlos

Meeting Abstract. 2023

Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.

Magaz, Marta; (...); Garcia-Pagan, Juan Carlos

Article. 10.1016/j.jhep.2024.07.035. 2024

• 
• 13

  

Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.

Ruiz-Cobo, Juan Carlos; (...); Buti, Maria

Article. 10.1111/apt.18020. 2024

• 
• 
• 3

  

Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

Ruiz-Cobo, Juan Carlos; (...); Lens, Sabela

Meeting Abstract. 2023

Real-world short-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA Registry

Iborra, M; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.629. 2019

• 
• 2

  

Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.

Crespo, Javier; (...); Calleja, Jose Luis

Practice Guideline. 10.1016/j.gastrohep.2022.09.009. 2023

• 
• 5

  

Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease.

Boscá MM; (...); Hinojosa J

Review. 10.1016/j.gastrohep.2019.09.012. 2020

• 
• 
• 25

  

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment.

Barreiro-de Acosta M; (...); Nos P

Article. 10.1016/j.gastrohep.2020.04.004. 2020

• 
• 
• 15

  

Recurrent alcohol-associated hepatitis is common and is associated with increased mortality.

Gratacos-Gines, Jordi; (...); Pose, Elisa

Article. 10.1097/HEP.0000000000000825. 2024

• 
• 1

  

Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial

Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos

Meeting Abstract. 2023

Sarcoidosis cutánea tras inyecciones de plasma rico en plaquetas y maquillaje permanente de cejas.

Martín-Torregrosa D; (...); Botella-Estrada R

Article. 10.1016/j.ad.2024.10.043. 2024

Sensitisation to textile dyes in Spain: Epidemiological situation (2019-2022).

Hernández Fernández CP; (...); Doval IG

Article. 10.1111/cod.14513. 2024

• 
• 
• 2

  

Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019-2021 epidemiological situation.

Hernandez Fernandez, Carlos Pelayo; (...); Garcia Doval, Ignacio

Article. 10.1111/cod.14251. 2022

• 
• 
• 7

  

Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC 1 national cross-sectional study.

Mercader-García P; (...); Borrego L

Article. 10.1111/cod.13837. 2021

• 
• 
• 10

  

Sodium metabisulfite a current low relevant allergen in Spain.

Sanz-Sanchez, Tatiana; (...); Borrego, Leopoldo

Letter. 10.1111/jdv.19702. 2023

• 
• 3

  

Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)

Navarro-Trivino, F. J.; (...); Armario-Hita, J. C.

Article. 10.1016/j.ad.2024.05.018. 2024

Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).

Navarro-Triviño FJ; (...); Carlos Armario-Hita J

Article. 10.1016/j.ad.2024.03.024. 2024

• 
• 
• 3

  

Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?

Cabezas, Joaquin; (...); Crespo, Javier

Meeting Abstract. 2023

SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?

Cabezas, Joaquin; (...); Crespo Garcia, Javier

Meeting Abstract. 2023

Sustained response to anti-TNF therapy in ASIA syndrome triggered by vaccination and filler.

Martin-Torregrosa, Daniel; (...); Rodriguez-Serna, Mercedes

Letter. 10.1111/ijd.17650. 2025

Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects.

Lasheras-Pérez MA; (...); Rodriguez-Serna M

Article. 10.1111/ijd.16926. 2024

• 4

  

The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study.

Echarri A; (...); Muñiz J

Article. 10.1089/tmj.2018.0264. 2020

• 
• 
• 23

  

Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study

Armario-Hita, Jose Carlos; (...); Ruiz-Villaverde, Ricardo

Article. 10.1111/ijd.17344. 2024

• 
• 
• 3

  

Treatment Persistence and Safety of Apremilast in Psoriasis: Experience With 30 Patients in Routine Clinical Practice

Sahuquillo-Torralba, A; (...); Estrada, RB

Article. 10.1016/j.ad.2018.10.031. 2020

• 
• 4

  

Zoon's vulvitis in association with severe vulvodynia.

Abril-Perez, Carlos; (...); Botella-Estrada R

Article. 10.1016/j.ajog.2022.01.033. 2022

• 
• 1